Need professional-grade analysis? Visit stockanalysis.com
$5.68M
N/A
N/A
N/A
Orgenesis Inc (ORGS) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $0.11, down 63.33% from the previous close.
Over the past year, ORGS has traded between a low of $0.00 and a high of $2.48. The stock has lost 95.3% over this period. It is currently 95.6% below its 52-week high.
Orgenesis Inc has a market capitalization of $5.68M.
Orgenesis Inc. is a global biotech company focused on the development of advanced cell and gene therapies. The company's main business is the development and commercialization of autologous cell therapies, which involve the use of a patient's own cells to treat various medical conditions. Orgenesis operates through its point-of-care (POCare) platform, which aims to bring cell and gene therapies closer to patients and make them more accessible.
Side-by-side comparison against top Healthcare peers.